Form 4: TransMedics Group Executive Acquires Shares and Stock Options

Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group, acquired shares and stock options on February 23, 2024.

Summary

• On February 23, 2024, Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group, acquired 11,441 shares of common stock in the form of restricted stock units (RSUs) at $0.00 per share.
• Each RSU represents a contingent right to receive one share of TransMedics Group's common stock.
• Corcoran also acquired options to purchase 17,632 shares of common stock at an exercise price of $83.14.
• The options vest monthly at a rate of 2.0833% starting February 23, 2024, and will be fully vested on February 23, 2028, contingent upon continued service.
• Following the transaction, Corcoran directly owns 24,327 shares of common stock and options for 17,632 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider ownership is generally viewed favorably, but the information is purely transactional.

Positives

• The acquisition of shares and options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates